Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMARC Enterprises is a health and wellness company primarily known for the development and distribution of Poly-MVA, a unique dietary supplement formulated with a proprietary Lipoic Acid Palladium Complex (LAPC). The company focuses on cellular health, mitochondrial support, and providing integrative options for patients dealing with chronic illnesses, including cancer and neurodegenerative diseases. Poly-MVA is designed to enhance energy production at the cellular level while acting as a potent antioxidant to protect DNA and cell structures. AMARC supports ongoing research and clinical observations to validate the efficacy of its formulations in improving quality of life and supporting conventional medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poly-MVA.